Standard
Simvastatin effects on skeletal muscle : relation to decreased mitochondrial function and glucose intolerance. / Larsen, Steen; Stride, Nis; Hey-Mogensen, Martin; Hansen, Christina N; Bang, Lia E; Bundgaard, Henning; Nielsen, Lars B; Helge, Jørn W; Dela, Flemming.
I:
Journal of the American College of Cardiology, Bind 61, Nr. 1, 08.01.2013, s. 44-53.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Larsen, S, Stride, N, Hey-Mogensen, M, Hansen, CN, Bang, LE
, Bundgaard, H, Nielsen, LB
, Helge, JW & Dela, F 2013, '
Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance',
Journal of the American College of Cardiology, bind 61, nr. 1, s. 44-53.
https://doi.org/10.1016/j.jacc.2012.09.036APA
Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Bang, L. E.
, Bundgaard, H., Nielsen, L. B.
, Helge, J. W., & Dela, F. (2013).
Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance.
Journal of the American College of Cardiology,
61(1), 44-53.
https://doi.org/10.1016/j.jacc.2012.09.036Vancouver
Larsen S, Stride N, Hey-Mogensen M, Hansen CN, Bang LE
, Bundgaard H o.a.
Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance.
Journal of the American College of Cardiology. 2013 jan. 8;61(1):44-53.
https://doi.org/10.1016/j.jacc.2012.09.036Author
Larsen, Steen ; Stride, Nis ; Hey-Mogensen, Martin ; Hansen, Christina N ; Bang, Lia E ; Bundgaard, Henning ; Nielsen, Lars B ; Helge, Jørn W ; Dela, Flemming. / Simvastatin effects on skeletal muscle : relation to decreased mitochondrial function and glucose intolerance. I: Journal of the American College of Cardiology. 2013 ; Bind 61, Nr. 1. s. 44-53.
Bibtex
@article{7ad14063856844f1a4d5c8c00c6b938f,
title = "Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance",
abstract = "Glucose tolerance and skeletal muscle coenzyme Q(10) (Q(10)) content, mitochondrial density, and mitochondrial oxidative phosphorylation (OXPHOS) capacity were measured in simvastatin-treated patients (n = 10) and in well-matched control subjects (n = 9).",
keywords = "Blood Glucose, Case-Control Studies, Cell Respiration, Electron Transport, Electron Transport Complex I, Electron Transport Complex II, Glucose Intolerance, Glucose Tolerance Test, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Insulin Resistance, Male, Middle Aged, Mitochondria, Muscle, Muscle Fibers, Skeletal, Muscle, Skeletal, Oxidative Phosphorylation, Simvastatin, Ubiquinone",
author = "Steen Larsen and Nis Stride and Martin Hey-Mogensen and Hansen, {Christina N} and Bang, {Lia E} and Henning Bundgaard and Nielsen, {Lars B} and Helge, {J{\o}rn W} and Flemming Dela",
note = "Copyright {\textcopyright} 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.",
year = "2013",
month = jan,
day = "8",
doi = "10.1016/j.jacc.2012.09.036",
language = "English",
volume = "61",
pages = "44--53",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier",
number = "1",
}
RIS
TY - JOUR
T1 - Simvastatin effects on skeletal muscle
T2 - relation to decreased mitochondrial function and glucose intolerance
AU - Larsen, Steen
AU - Stride, Nis
AU - Hey-Mogensen, Martin
AU - Hansen, Christina N
AU - Bang, Lia E
AU - Bundgaard, Henning
AU - Nielsen, Lars B
AU - Helge, Jørn W
AU - Dela, Flemming
N1 - Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
PY - 2013/1/8
Y1 - 2013/1/8
N2 - Glucose tolerance and skeletal muscle coenzyme Q(10) (Q(10)) content, mitochondrial density, and mitochondrial oxidative phosphorylation (OXPHOS) capacity were measured in simvastatin-treated patients (n = 10) and in well-matched control subjects (n = 9).
AB - Glucose tolerance and skeletal muscle coenzyme Q(10) (Q(10)) content, mitochondrial density, and mitochondrial oxidative phosphorylation (OXPHOS) capacity were measured in simvastatin-treated patients (n = 10) and in well-matched control subjects (n = 9).
KW - Blood Glucose
KW - Case-Control Studies
KW - Cell Respiration
KW - Electron Transport
KW - Electron Transport Complex I
KW - Electron Transport Complex II
KW - Glucose Intolerance
KW - Glucose Tolerance Test
KW - Humans
KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW - Insulin Resistance
KW - Male
KW - Middle Aged
KW - Mitochondria, Muscle
KW - Muscle Fibers, Skeletal
KW - Muscle, Skeletal
KW - Oxidative Phosphorylation
KW - Simvastatin
KW - Ubiquinone
U2 - 10.1016/j.jacc.2012.09.036
DO - 10.1016/j.jacc.2012.09.036
M3 - Journal article
C2 - 23287371
VL - 61
SP - 44
EP - 53
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
SN - 0735-1097
IS - 1
ER -
